| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $49,779,326 ) (Continued on the next page) |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | CoVPN 5002: SARS-CoV-2 Prevalence Study -Supplement Request | 001 | 20 | NIH | 11/21/2024 | $5,399,174 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI167004 | In Vivo Gene Editing of B cells with NICE-AAV Vectors | 000 | 5 | NIH | 11/25/2024 | $605,441 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R13AI189265 | Flow Cytometry Workshops in Africa | 000 | 1 | NIH | 12/1/2024 | $25,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 000 | 20 | NIH | 11/30/2024 | $9,809,377 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 000 | 20 | NIH | 11/30/2024 | $7,793,642 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 000 | 20 | NIH | 11/30/2024 | $250,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 000 | 20 | NIH | 11/30/2024 | $500,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01HL161037 | Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | 000 | 5 | NIH | 11/22/2024 | $668,582 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068618 | CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC Repository | 000 | 20 | NIH | 11/25/2024 | $8,676,243 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068618 | CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC Repository | 000 | 20 | NIH | 11/25/2024 | $6,336,305 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068618 | CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC Repository | 000 | 20 | NIH | 11/25/2024 | $400,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA276308 | Transcriptional-translational conflict in bladder epithelial homeostasis and cancer | 000 | 3 | NIH | 11/22/2024 | $512,155 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA277133 | Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies | 000 | 3 | NIH | 11/15/2024 | $361,548 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA114536 | Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy | 000 | 20 | NIH | 11/21/2024 | $392,157 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA287476 | Interrogating a novel axis of tumor suppression in small cell lung cancer | 000 | 1 | NIH | 11/14/2024 | $548,915 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI170214 | Developing Durable, Env-Boosted CAR T Cells for HIV Cure | 000 | 3 | NIH | 10/31/2024 | $814,373 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA287573 | Interrogating roles for REST in small cell lung cancer therapy response and resistance | 000 | 2 | NIH | 11/6/2024 | $523,869 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R37CA230617 | Hormone signaling and translation control in advanced prostate cancer | 001 | 8 | NIH | 11/1/2024 | $390,547 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle-Lausanne Clinical Trials Unit | 000 | 20 | NIH | 11/7/2024 | $141,120 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle-Lausanne Clinical Trials Unit | 000 | 20 | NIH | 11/7/2024 | $699,159 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | CoVPN 5002: SARS-CoV-2 Prevalence Study -Supplement Request | 001 | 20 | NIH | 11/21/2024 | $3,656,634 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | CoVPN 5002: SARS-CoV-2 Prevalence Study -Supplement Request | 001 | 20 | NIH | 11/21/2024 | $732,039 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI167004 | In Vivo Gene Editing of B cells with NICE-AAV Vectors | 000 | 5 | NIH | 11/25/2024 | $125,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | CoVPN 5002: SARS-CoV-2 Prevalence Study -Supplement Request | 001 | 20 | NIH | 11/21/2024 | $636,816 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 000 | 7 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM148166 | Biophysical and structural studies of protein and enzyme mechanism, evolution, and engineering | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM139429 | Molecular mechanisms and functions of global chromatin control | 000 | 5 | NIH | 11/4/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM149357 | Mechanisms underlying chromosome segregation | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U54CA132381 | 2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch | 000 | 18 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119835 | Regulation of Protein Synthesis by Synonymous Codon Usage | 000 | 10 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119774 | Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation | 000 | 10 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35CA274442 | Modeling and analytics for cancer diagnostics: traversing the data-evidence divide | 000 | 3 | NIH | 10/9/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24CA086368 | The Early Detection Research Network: Data Management and Coordinating Center | 001 | 24 | NIH | 10/30/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24CA086368 | The Early Detection Research Network: Data Management and Coordinating Center | 000 | 24 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI177095 | Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization | 000 | 1 | NIH | 10/29/2024 | $393,857 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA247548 | Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study | 000 | 5 | NIH | 10/17/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement for PBMCs and RNA PaxGene | 001 | 2 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement for PBMCs and RNA PaxGene | 001 | 2 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) Administrative Supplement for PBMCs and RNA PaxGene | 000 | 2 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA270441 | Using a SMART design to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors | 000 | 2 | NIH | 10/17/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA253915 | Modeling Precision Interventions for Prostate Cancer Control | 000 | 6 | NIH | 10/24/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U54CA274374 | Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | 001 | 3 | NIH | 11/25/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U54CA274374 | Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | 000 | 3 | NIH | 10/15/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA271407 | Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies | 000 | 3 | NIH | 10/31/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA256969 | Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy | 000 | 4 | NIH | 11/29/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI179457 | Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence | 000 | 1 | NIH | 11/25/2024 | $269,858 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U19AI174242 | Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs | 000 | 2 | NIH | 11/22/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U19MD020533 | CANOE Partnership: Cancer Awareness, Navigation, Outreach, and Equitable Indigenous Health Outcomes | 000 | 1 | NIH | 11/21/2024 | $0 |
| | 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM141457 | Molecular modeling and machine learning for protein structures and interactions | 000 | 5 | NIH | 11/18/2024 | $0 |
|
